| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Virpax Pharmaceuticals, Inc. | Director | Stock Option (right to buy) | 2,500 | 05 Jul 2024 | Direct | ||
| LQR House Inc. | Director | Restricted Stock Units | 0 | 14 Oct 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| YHC | LQR House Inc. | 14 Oct 2024 | 1 | $0 | 4 | Director | 16 Oct 2024, 16:05 |
| VRPX | Virpax Pharmaceuticals, Inc. | 05 Jul 2024 | 1 | $0 | 4 | Director | 09 Jul 2024, 16:02 |
| VRPX | Virpax Pharmaceuticals, Inc. | 05 Jul 2024 | 0 | $0 | 3 | Director | 09 Jul 2024, 16:00 |
| YHC | LQR House Inc. | 21 Aug 2023 | 0 | $0 | 3 | Director | 11 Apr 2024, 16:05 |